U.S. Biomarkers Market Size & Outlook, 2026-2033

Name: U.S. Biomarkers Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biomarkers market in the United States is expected to reach a projected revenue of US$ 108,528.4 million by 2033. A compound annual growth rate of 13.57% is expected of the United States biomarkers market from 2026 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Biomarkers Market Outlook

U.S. biomarkers type outlook (Revenue, USD million, 2021-2033)
- Safety
- Efficacy
- Validation
U.S. biomarkers application outlook (Revenue, USD million, 2021-2033)
- Diagnostics
- Drug discovery & development
- Personalized Medicine
- Others
U.S. biomarkers disease outlook (Revenue, USD million, 2021-2033)
- Cancer
  - Safety
  - Efficacy
  - Validation
- Cardiovascular Diseases
  - Safety
  - Efficacy
  - Validation
- Neurological Diseases
  - Safety
  - Efficacy
  - Validation
- Immunological diseases Diseases
  - Safety
  - Efficacy
  - Validation
- Others
  - Safety
  - Efficacy
  - Validation

U.S. Biomarkers Market Size & Outlook, 2026-2033

Data Tree

Sign up - it's easy, and free!